127. Frontotemporal lobar degeneration
74 clinical trials,   83 drugs   (DrugBank: 28 drugs),   29 drug target genes,   99 drug target pathways

Searched query = "Frontotemporal lobar degeneration", "Frontotemporal dementia", "Semantic dementia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00545974
(ClinicalTrials.gov)
October 200716/10/2007Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal DementiaA Prospective, Randomized, Multi-Center, Double-Blind, 26 Week, Placebo-Controlled Trial of Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal DementiaFrontal Lobe Dementia;Frontotemporal Lobe Dementia;Semantic DementiaDrug: memantine;Drug: Placebo pillUniversity of California, San FranciscoForest LaboratoriesCompleted40 Years80 YearsAll81Phase 4United States
2NCT00594737
(ClinicalTrials.gov)
October 20077/1/2008Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal DementiaAn Open Label Pilot Study of the Effects of Memantine Administration on FDG-PET in Frontotemporal DementiaFrontotemporal DementiaDrug: memantine hydrochlorideTiffany Chow, MDH. Lundbeck A/SCompleted40 Years80 YearsBoth17Phase 3Canada
3NCT00200538
(ClinicalTrials.gov)
September 200512/9/2005Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) PatientsDouble-blind, Parallel Group, Placebo-controlled Trial of the Efficacy and Tolerability of Memantine (20 mg) in Frontotemporal Dementia (FTD) PatientsDementiaDrug: memantineNantes University HospitalNULLCompleted45 Years75 YearsBoth52Phase 2France
4NCT00187525
(ClinicalTrials.gov)
May 200413/9/2005A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar DegenerationFrontotemporal Lobar DegenerationDrug: MemantineUniversity of California, San FranciscoForest LaboratoriesCompleted40 Years80 YearsBothPhase 4NULL